InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,193.77
(
0.25%
)
US TECH 100
17,670.40
(
0.34%
)
Dow Jones
38,920.60
(
0.18%
)
Brent Oil
82.86
(
-0.74%
)
Bitcoin
63,706.90
(
0.86%
)
Post# of 878
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ejobkar

Send PM Follow Ignore
Followers 4
Posts 798
Boards Moderated 0
Alias Born 03/05/2012

ejobkar

Re: someconcerns post# 676

Sunday, 09/15/2019 7:23:49 PM

Sunday, September 15, 2019 7:23:49 PM

Post# of 878
I honestly didn't think .05s would hit but its a great time to buy the weakness! The bid sizes are increasing (200k+) in the .05 range recently, so it won't be long until we push up again.


Per Tailwinds...

BioVie (BIVI): September and October portend to be an important months for BioVie. The Company should be filing their protocols with the FDA for the upcoming phase 2b/3 trial. After which, they are likely tapping the markets for $15M simultaneous with a reverse split and an uplisting to Nasdaq. The drug works and should be able to gain approval. The stock is cheap and the CEO, Terren Peizer, is a smart investor who owns a large majority of the Company. I’ll be increasing my position when they complete the financing and maybe even somewhat in advance if the stock stays weak.


https://tailwindsresearch.com/2019/09/fall-investor-preview-along-with-a-belated-august-recap/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BIVI News
More BIVI News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!